Roche will invest $50 billion in U.S. manufacturing, including a new plant in Indiana. The Trump administration is considering tariffs on drugmakers.

Eli Lilly gains analyst support after Phase 3 success. Bullish forecasts for obesity dominance and key earnings are set for ...

Novo Nordisk, maker of Ozempic, applied for FDA approval for a weight loss pill, less than a week after rival Eli Lilly's clinical trial success.

Lilly Broadcasting has capitalized on its ability to bring viewers across Puerto Rico and the U.S. Virgin Islands customized ...

Middle-aged people in the United States experience more loneliness than seniors, researchers reported Tuesday in the journal ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Senior Health Correspondent for TIME, Alice Park, gives us a deeper look into how Eli Lilly's new pill orforglipron may ...

The National Institutes of Health will provide private health data to researchers for U.S. health chief Robert F. Kennedy Jr.

Trump proposed a change to Medicare price talks that has long been sought after by the pharmaceutical industry.

Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

The Swiss pharma giant made one of the most significant financial promises to bolster its domestic manufacturing capabilities as the Trump administration weighs levying tariffs on drugmakers.

Following competitor Novartis, pharma giant Roche also announces massive investments in the United States. Swiss jobs and ...